Gallimix-200 WS is a macrolide antibiotic indicated for the treatment of infectious diseases due to erythromycin-sensitive bacteria and Mycoplasma in poultry. Erythromycin binds reversibly to the 50S subunit of ribosomes, resulting in the blockage of transpeptidation or translocation reactions, leading to impaired and/or inhibited protein synthesis and, hence, to inhibited cell growth.
Gallimix-200 WS is indicated for the treatment of Chronic Respiratory Disease (CRD) caused by Mycoplasma infections, and for the treatment of infectious (respiratory) diseases due to erythromycin-sensitive bacteria such as Staphylococcus aureus (e.g. infectious arthritis), Haemophilus paragallinarum (e.g. infectious coryza) and Pasteurella multocida (e.g. pasteurellosis; pneumonia) in poultry.
Hypersensitivity to erythromycin.
Administration to animals with a seriously impaired hepatic and/or renal function.
Concurrent administration of tetracyclines, chloramphenicol, macrolides and lincosamides.
Hypersensitivity reactions may occur.
For oral administration.
100 g per 100 litres of drinking water for 3 - 5 days.
- For meat : 3 days.
- For eggs : 6 days.